Products & Services · Cost of Sales
Tyvaso DPI — Cost of Sales
United Therapeutics Tyvaso DPI — Cost of Sales increased by 41.7% to $83.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 73.0%, from $48.10M to $83.20M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toTotal Cost of Revenue
How to read this metric
An increase relative to revenue may signal rising production costs or supply chain inefficiencies, while a decrease suggests improved manufacturing margins or economies of scale.
Detailed definition
Includes the direct costs associated with manufacturing, packaging, and distributing a specific pharmaceutical product....
Peer comparison
Commonly reported as Cost of Goods Sold (COGS) for specific product segments in the life sciences industry.
Metric ID:
uthr_segment_tyvaso_dpi_cost_of_salesHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $10.30M | $20.70M | $33.00M | $31.10M | $30.80M | $33.30M | $37.60M | $39.10M | $38.40M | $48.10M | $48.50M | $55.30M | $58.70M | $83.20M |
| QoQ Change | — | — | — | — | +101.0% | +59.4% | -5.8% | -1.0% | +8.1% | +12.9% | +4.0% | -1.8% | +25.3% | +0.8% | +14.0% | +6.1% | +41.7% |
| YoY Change | — | — | — | — | — | — | +201.9% | — | +60.9% | +13.9% | +25.7% | +24.7% | +44.4% | +29.0% | +41.4% | +52.9% | +73.0% |
Range$0.00 – $83.20M
Avg YoY Growth+56.8%
Median YoY Growth+42.9%
Current Streak5 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's tyvaso dpi — cost of sales?
- United Therapeutics (UTHR) reported tyvaso dpi — cost of sales of $83.20M in Q1 2026.
- How has United Therapeutics's tyvaso dpi — cost of sales changed year-over-year?
- United Therapeutics's tyvaso dpi — cost of sales increased by 73.0% year-over-year, from $48.10M to $83.20M.
- What does tyvaso dpi — cost of sales mean?
- The direct costs incurred to manufacture and supply a specific product.